generex biotechnology corporation product pipeline

1

Generex Biotechnology Corporation - Product Pipeline

Review – 2015 Is Released

Generex Biotechnology Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct s,

Generex Biotechnology Corporation - Product Pipeline Review - 2015, provides an overview of the

Generex Biotechnology Corporations pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of

Generex Biotechnology Corporations, complete with comparative analysis at various stages,

therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and

molecule type. It also reviews latest updates, and featured news and press releases, along with special

features on late-stage and discontinued projects. Global Markets Directs report features investigational

drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built

using data and information sourced from Global Markets Directs proprietary databases,

Company/University websites, SEC filings, investor presentations and featured press releases from

company/university sites and industry-specific third party sources, put together by Global Markets

Directs team. Drug profiles/records featured in the report undergoes periodic updation following a

stringent set of processes that ensures that all the profiles are updated with the latest set of

information. Additionally, processes including live news & deals tracking, browser based alert-box and

clinical trials registries tracking ensure that the most recent developments are captured on a real time

basis. The report enhances decision making capabilities and help to create effective counter strategies

to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to

produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed

or altered based on the availability and relevance of data for the indicated disease. Scope - The report

provides brief overview of Generex Biotechnology Corporation including business description, key

information and facts, and its locations and subsidiaries - The report reviews current pipeline of Generex

Biotechnology Corporations human therapeutic division and enlists all their major and minor projects -

The report features product description and descriptive mechanism of action for key pipeline products

along with the products developmental history and major milestones - Special feature on out-licensed

and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects - Latest company statement -

Latest news and deals relating to the Generex Biotechnology Corporations pipeline products Reasons to

buy - Evaluate Generex Biotechnology Corporations strategic position with total access to detailed

information on its product pipeline - Assess the growth potential of Generex Biotechnology Corporation

in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Generex

Biotechnology Corporation s R&D portfolio and develop key strategic initiatives to reinforce pipeline in

those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio

gaps - Develop strategic initiatives by understanding the focus areas of Generex Biotechnology

Corporation and exploit collaboration and partnership opportunities - Identify emerging players with

potentially strong product portfolio and create effective counter-strategies to gain competitive

advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of

Generex Biotechnology Corporation - Develop and design in-licensing and out-licensing strategies by

identifying prospective partners with the most attractive projects to enhance and expand business

2

potential and scope - Explore the dormant and discontinued projects of Generex Biotechnology

Corporation and identify potential opportunities in those areas - Avoid Intellectual Property Rights

related issues

Browse Complete Report with TOC http://www.idatainsights.com/reports-landing-

page.php?id=179135/generex-biotechnology-corporation-product-pipeline-review-2015

To Get Sample Copy of Report visit http://www.idatainsights.com/reports-landing-

page.php?id=179135/generex-biotechnology-corporation-product-pipeline-review-2015

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Generex Biotechnology Corporation Snapshot 5

Generex Biotechnology Corporation Overview 5

Key Information 5

Key Facts 5

Generex Biotechnology Corporation - Research and Development Overview 6

Key Therapeutic Areas 6

Generex Biotechnology Corporation - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Generex Biotechnology Corporation - Pipeline Products Glance 10

Generex Biotechnology Corporation - Late Stage Pipeline Products 10

Phase III Products/Combination Treatment Modalities 10

Generex Biotechnology Corporation - Clinical Stage Pipeline Products 11

Phase I Products/Combination Treatment Modalities 11

Generex Biotechnology Corporation - Drug Profiles 12

3

insulin human 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

AE-IG vaccine 14



R&D Progress 14

AE-O vaccine 15



R&D Progress 15

fentanyl citrate 16



R&D Progress 16

morphine sulfate 17



R&D Progress 17

Polysaccharide to Inhibit Factor X for Deep Vein Thrombosis 18



R&D Progress 18

4

Generex Biotechnology Corporation - Pipeline Analysis 19

Generex Biotechnology Corporation - Pipeline Products by Target 19

Generex Biotechnology Corporation - Pipeline Products by Route of Administration 20

Generex Biotechnology Corporation - Pipeline Products by Molecule Type 21

Generex Biotechnology Corporation - Pipeline Products by Mechanism of Action 22

Generex Biotechnology Corporation - Recent Pipeline Updates 23

Generex Biotechnology Corporation - Dormant Projects 24

Generex Biotechnology Corporation - Company Statement 25

Generex Biotechnology Corporation - Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Appendix 29

Methodology 29

Coverage 29

Secondary Research 29

Primary Research 29

Expert Panel Validation 29

Contact Us 29

Disclaimer 30" width="80" height="40" />Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Generex Biotechnology Corporation Snapshot 5

5

Generex Biotechnology Corporation Overview 5

Key Information 5

Key Facts 5

Generex Biotechnology Corporation - Research and Development Overview 6

Key Therapeutic Areas 6

Generex Biotechnology Corporation - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Generex Biotechnology Corporation - Pipeline Products Glance 10

Generex Biotechnology Corporation - Late Stage Pipeline Products 10

Phase III Products/Combination Treatment Modalities 10

Generex Biotechnology Corporation - Clinical Stage Pipeline Products 11

Phase I Products/Combination Treatment Modalities 11

Generex Biotechnology Corporation - Drug Profiles 12

insulin human 12



R&D Progress 12

AE-IG vaccine 14



R&D Progress 14

AE-O vaccine 15


6


R&D Progress 15

fentanyl citrate 16



R&D Progress 16

morphine sulfate 17



R&D Progress 17

Polysaccharide to Inhibit Factor X for Deep Vein Thrombosis 18



R&D Progress 18

Generex Biotechnology Corporation - Pipeline Analysis 19

Generex Biotechnology Corporation - Pipeline Products by Target 19

Generex Biotechnology Corporation - Pipeline Products by Route of Administration 20

Generex Biotechnology Corporation - Pipeline Products by Molecule Type 21

Generex Biotechnology Corporation - Pipeline Products by Mechanism of Action 22

Generex Biotechnology Corporation - Recent Pipeline Updates 23

Generex Biotechnology Corporation - Dormant Projects 24

Generex Biotechnology Corporation - Company Statement 25

Generex Biotechnology Corporation - Locations And Subsidiaries 28

7

Head Office 28

Other Locations & Subsidiaries 28

Appendix 29

Methodology 29

Coverage 29

Secondary Research 29

Primary Research 29

Expert Panel Validation 29

Contact Us 29

Disclaimer 30

Read More http://www.idatainsights.com/reports-landing-page.php?id=179135/generex-

biotechnology-corporation-product-pipeline-review-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading

market research information aggregator and marketing research consulting firm. We conduct both

primary and secondary research. Our work does not end with research it is also involved in distributing

reports for different companies . We provide actionable recommendations and provide our expertise for

business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and

discovery, and then be their guide in the implementation of changes that will make a difference to their

bottom line.

ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: [email protected] About iData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our

mission to provide timely services coupled with acute client care to create a long-lasting relationship

with you. We deliver on our promise to provide results that are essential to the success of your

company. We believe that by doing so, we will earn the trust of our clients for future project.

http://www.idatainsights.com/

generex biotechnology corporation product pipeline

Documents